Focus: Colorado Therapeutics is a private biotechnology company headquartered in Louisville, CO, specializing in crosslinked soft tissue repair materials with a focus on oncology applications. The company operates at an early-stage development level with a diversified pipeline spanning multiple therapeutic areas.
Profile data last refreshed 17h ago · AI intelligence enriched 1w ago
No open roles listed right now. Follow Colorado Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Colorado Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Post-loss-of-exclusivity ANDA generic with limited clinical relevance; serotonin and histamine antagonist with unclear commercial viability.
Help build intelligence for Colorado Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Post-LOE CNS stimulant ANDA with established clinical utility but mature, competitive generics market.
Ultramicrocrystalline antifungal ANDA with fungistatic activity; post-LOE status indicates mature lifecycle with limited growth potential.
Skeletal muscle relaxant ANDA with post-LOE status; mechanism of action incompletely characterized, indicating older therapeutic.
1 discontinued, 0 duplicate formulations not shown
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moSource: USCIS H-1B Employer Data Hub